Revised British Isles Lupus Assessment Group (BILAG) Index 2004

Purpose: To evaluate a patient with systemic lupus erythematosus (SLE) using the British Isles Lupus Assessment Group (BILAG) revised index from 2004.

Info MyLikes MyPaths

Evaluation

Are you evaluating a patient with SLE?

Yes

Select the appropriate answer for each disease activity in each system

Constitutional

Mucocutaneous

Neuropsychiatric

Musculoskeletal

Cardiorespiratory

Gastrointestinal

Renal

Hematological

Ophthalmic

Results

Please fill out required fields.

Results Interpretation and Description References Next Steps

Data complete?

Evaluation appropriate?

Total score

Number of components with marked activity

Number of components with moderate activity

Number of components with mild activity

Number of components that are inactive

Number of components that have never shown any activity

MedicalAlgorithms.com APIs

Power Your Solutions with 5,000+ Automated Medical Analytics

Seamlessly integrate our API library of over 5,000 evidence-based medical analytics into your products and workflows. Our APIs help you:

Build custom, automated clinical workflows tailored to your organization's needs.
Enhance your clinical decision support with advanced, evidence-based analytics.
Streamline revenue cycle management by integrating clinical analytics into billing, coding, and compliance processes.
Support payment and pre-approval processes with automated, standardized medical criteria.
Embed proven medical algorithms directly into your systems and services for consistent, high-quality outcomes.

With MedicalAlgorithms.com APIs, you can accelerate innovation, improve efficiency, and deliver more accurate, data-driven care—without reinventing the wheel.

Explore Medal API

Caution: A qualified health practitioner should verify all results.
Keep patient data confidential and comply with all legal requirements.

Please visit our website Medicalalgorithms.com for Description and Interpretation and further algorithms you may want to consider in the next steps of your evaluation. All information should be verified by a qualified health professional, and all use is subject to Medicalalgorithms.com Terms and Conditions. © Copyright Medicalalgorithms.com Limited

Interpretation and Description

References

Next Steps in Evaluation

Diagnosis

Risk Factors
Clinical Diagnosis, Including Family History For Genetics
Imaging Studies
Laboratory Tests
Other Testing
- Clinical Features of Acute Lupus Pneumonitis
Criteria For Diagnosis
Severity, Prognosis, Stage
Complications
- Systemic Lupus Erythematosus (SLE) | Moyamoya Syndrome
Differential Diagnosis And Mimics, Red Flags

Therapy

Pharmacogenetics
Drug Interactions
- SELENA Flare Tool
- Diagnostic Features of Drug-Induced Lupus Erythematosus (DIL)
Prevention
Interventional Radiology

Monitoring

Drug Levels
- SELENA Flare Tool
- Diagnostic Features of Drug-Induced Lupus Erythematosus (DIL)
Disease Progression
Complication Detection
Comorbid Conditions

Patient Concerns

Quality Of Life
Psychological Response

Specialty

Immunology/Rheumatology

Objective

imaging studies
laboratory tests
criteria for diagnosis
disease progression
complication detection

ICD-10

M32 - Systemic lupus erythematosus

Info

Purpose: To evaluate a patient with systemic lupus erythematosus (SLE) using the British Isles Lupus Assessment Group (BILAG) revised index from 2004.

Specialty: Immunology/Rheumatology

Objective: imaging studies, laboratory tests, criteria for diagnosis, disease progression, complication detection

ICD-10: M32,

Save Data

Identifier

Enter 1 to 5 characters as ID

Email

Your registered email

Other

Email to

Please separate multiple email IDs with comma (,)

Consult Report

Identifier

Enter 1 to 5 characters as ID

Add to MyPath

Select path

New path